These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31492872)

  • 1. Proliferation Tumour Marker Network (PTM-NET) for the identification of tumour region in Ki67 stained breast cancer whole slide images.
    Joseph J; Roudier MP; Narayanan PL; Augulis R; Ros VR; Pritchard A; Gerrard J; Laurinavicius A; Harrington EA; Barrett JC; Howat WJ
    Sci Rep; 2019 Sep; 9(1):12845. PubMed ID: 31492872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.
    Thakur SS; Li H; Chan AMY; Tudor R; Bigras G; Morris D; Enwere EK; Yang H
    PLoS One; 2018; 13(1):e0188983. PubMed ID: 29304138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated quantitative analysis of Ki-67 staining and HE images recognition and registration based on whole tissue sections in breast carcinoma.
    Feng M; Deng Y; Yang L; Jing Q; Zhang Z; Xu L; Wei X; Zhou Y; Wu D; Xiang F; Wang Y; Bao J; Bu H
    Diagn Pathol; 2020 May; 15(1):65. PubMed ID: 32471471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.
    Min KW; Kim DH; Do SI; Pyo JS; Chae SW; Sohn JH; Kim K; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kwon MJ; Moon KM
    Postgrad Med J; 2016 Dec; 92(1094):707-714. PubMed ID: 27222586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assessment of Ki67 staining using cell line proliferation index and stain intensity features.
    Lanng MB; Møller CB; Andersen AH; Pálsdóttir ÁA; Røge R; Østergaard LR; Jørgensen AS
    Cytometry A; 2019 Apr; 95(4):381-388. PubMed ID: 30556331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative Index (Ki67) for Prediction in Breast Duct Carcinomas.
    Ahmed ST; Ahmed AM; Musa DH; Sulayvani FK; Al-Khyatt M; Pity IS
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):955-959. PubMed ID: 29693354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers.
    Yagi T; Inoue N; Yanai A; Murase K; Imamura M; Miyagawa Y; Enomoto Y; Nishimukai A; Takatsuka Y; Hirota S; Akazawa K; Miyoshi Y
    Breast Cancer; 2016 Mar; 23(2):224-30. PubMed ID: 25082658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.
    Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
    Breast Cancer Res Treat; 2018 May; 169(1):33-42. PubMed ID: 29349710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated characterization and counting of Ki-67 protein for breast cancer prognosis: A quantitative immunohistochemistry approach.
    Mungle T; Tewary S; Arun I; Basak B; Agarwal S; Ahmed R; Chatterjee S; Maity AK; Chakraborty C
    Comput Methods Programs Biomed; 2017 Feb; 139():149-161. PubMed ID: 28187885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancer.
    Horii R; Tsuda H; Masuda S; Sugita H; Togashi K; Ohno S; Akiyama F
    Breast Cancer; 2020 Nov; 27(6):1058-1064. PubMed ID: 32440959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of predictive markers (hormone receptors, Her2, Ki67) and intrinsic subtypes of breast cancer in four consecutive years 2015-2018.
    Stevanovic L; Choschzick M; Moskovszky L; Varga Z
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):2983-2994. PubMed ID: 31628534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous measurement of breast tumour hormone receptor expression: a comparison of two computational pathology platforms.
    Ahern TP; Beck AH; Rosner BA; Glass B; Frieling G; Collins LC; Tamimi RM
    J Clin Pathol; 2017 May; 70(5):428-434. PubMed ID: 27729430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A deep learning based holistic diagnosis system for immunohistochemistry interpretation and molecular subtyping.
    Fan L; Liu J; Ju B; Lou D; Tian Y
    Neoplasia; 2024 Apr; 50():100976. PubMed ID: 38412576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score.
    Robertson S; Acs B; Lippert M; Hartman J
    Breast Cancer Res Treat; 2020 Aug; 183(1):161-175. PubMed ID: 32572716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of Ki67 visual scoring app compared to eyeball estimate and digital image analysis and its prognostic significance in hormone receptor-positive breast cancer.
    Arun I; Venkatesh S; Ahmed R; Agrawal SK; Leung SCY
    APMIS; 2021 Aug; 129(8):489-502. PubMed ID: 34053140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.
    Rexhepaj E; Brennan DJ; Holloway P; Kay EW; McCann AH; Landberg G; Duffy MJ; Jirstrom K; Gallagher WM
    Breast Cancer Res; 2008; 10(5):R89. PubMed ID: 18947395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ki67 Frequency in Breast Cancers without Axillary Lymph Node Involvement and its Relation with Disease-free Survival.
    Shandiz FH; Shabahang H; Afzaljavan F; Sharifi N; Tavasoli A; Afzalaghaee M; Roshanzamir E; Pasdar A
    Asian Pac J Cancer Prev; 2016; 17(3):1347-50. PubMed ID: 27039770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying tumor in pancreatic neuroendocrine neoplasms from Ki67 images using transfer learning.
    Niazi MKK; Tavolara TE; Arole V; Hartman DJ; Pantanowitz L; Gurcan MN
    PLoS One; 2018; 13(4):e0195621. PubMed ID: 29649302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menstrual cycle could affect Ki67 expression in estrogen receptor-positive breast cancer patients.
    Horimoto Y; Arakawa A; Tanabe M; Kuroda K; Matsuoka J; Igari F; Himuro T; Yoshida Y; Tokuda E; Shimizu H; Hino O; Saito M
    J Clin Pathol; 2015 Oct; 68(10):825-9. PubMed ID: 26060263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value.
    Joshi S; Watkins J; Gazinska P; Brown JP; Gillett CE; Grigoriadis A; Pinder SE
    BMC Cancer; 2015 Jul; 15():546. PubMed ID: 26205655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.